Evidence map›Paper›PMID 36810309›Full record

ArticleArchives of disease in childhood. Fetal and neonatal edition2023

Two-year outcomes following a randomised platelet transfusion trial in preterm infants.

Carmel Maria Moore, Angela D'Amore, Suzanne Fustolo-Gunnink, Cara Hudson, Alice Newton, Beatriz Lopez Santamaria, Alison Deary, Renate Hodge, Valerie Hopkins, Ana Mora and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Archives of disease in childhood. Fetal and neonatal edition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Platelet transfusion thresholds for thrombocytopenic infants.The Cochrane database of systematic reviews · 2026
    Pooled it
  2. Pooled it
  3. Observational
  4. Redefining neonatal thrombocytopenia: an evidence-based approach, improved by the refineR algorithm.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Decreasing packed red blood cell (pRBC) transfusions in neonates through quality improvement.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  11. Designing and implementing a clinical decision support tool to improve compliance with NICU transfusions.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Review
  12. Review
  13. Article
  14. An improvement project standardizing low prophylactic platelet transfusion dosing for infants.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Article
  15. Development and implementation of restrictive platelet transfusion thresholds in a neonatal intensive care unit.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Article
  16. Using a lower platelet transfusion threshold: translating evidence into practice.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 12 institutions in 5 countries.

Carmel Maria MooreSchool of Medicine, University College Dublin, Dublin, Ireland carmel.moore@ucdconnect.ie.ORCID http://orcid.org/0000-0003-4164-3195
Angela D'AmoreNeonatology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Suzanne Fustolo-GunninkClinical Transfusion Research, Sanquin, Amsterdam, The Netherlands.
Cara HudsonClinical Trials Unit, NHS Blood and Transplant, Bristol, UK.
Alice NewtonClinical Trials Unit, NHS Blood and Transplant, Bristol, UK.
Beatriz Lopez SantamariaNeonatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Alison DearyClinical Trials Unit, NHS Blood and Transplant, Bristol, UK.
Renate HodgeClinical Trials Unit, NHS Blood and Transplant, Bristol, UK.
Valerie HopkinsClinical Trials Unit, NHS Blood and Transplant, Bristol, UK.
Ana MoraClinical Trials Unit, NHS Blood and Transplant, Bristol, UK.
Charlotte LlewelynClinical Trials Unit, NHS Blood and Transplant, Bristol, UK.
Vidheya VenkateshNICU, Cloudnine Hospital, Bengaluru, Karnataka, India.
Rizwan KhanNICU, University Maternity Hospital Limerick, Limerick, Ireland.
Karen WilloughbyNeonatology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Wes OnlandNeonatology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.
Karin FijnvandraatPediatrics, Emma Children's Hospital, Pediatric Hematology, University of Amsterdam, Amsterdam, The Netherlands.
Helen V NewPaediatric Transfusion Medicine, NHS Blood and Transplant, London, UK.
Paul ClarkeNeonatal Intensive Care Unit, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.ORCID http://orcid.org/0000-0001-6203-7632
Enrico LoprioreNeonatology, Leiden Universitair Medisch Centrum, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-3513-5066
Timothy WattsNeonatal Intensive Care Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Simon StanworthNational Health Service Blood and Transplant, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Anna CurleySchool of Medicine, University College Dublin, Dublin, Ireland.
PlaNeT2 MATISSE
NHS Blood and Transplant · GBCambridge University Hospitals NHS Foundation Trust · GBGuy's and St Thomas' NHS Foundation Trust · GBUniversity College Dublin · IEAmsterdam University Medical Centers · NLCloudnine · INEmma Kinderziekenhuis · NLLeiden University Medical Center · NLNational Health Service · GBSanquin · NLUniversity Maternity Hospital Limerick · IEUniversity of East Anglia · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAssess mortality and neurodevelopmental outcomes at 2 years of corrected age in children who participated in the PlaNeT-2/MATISSE (Platelets for Neonatal Transfusion - 2/Management of Thrombocytopenia in Special Subgroup) study, which reported that a higher platelet transfusion threshold was associated with significantly increased mortality or major bleeding compared to a lower one.

designRandomised clinical trial, enrolling from June 2011 to August 2017. Follow-up was complete by January 2020. Caregivers were not blinded; however, outcome assessors were blinded to treatment group.

setting43 level II/III/IV neonatal intensive care units (NICUs) across UK, Netherlands and Ireland. PATIENTS: 660 infants born at less than 34 weeks' gestation with platelet counts less than 50×10

interventionsInfants were randomised to undergo a platelet transfusion at platelet count thresholds of 50×10 MAIN OUTCOMES MEASURES: Our prespecified long-term follow-up outcome was a composite of death or neurodevelopmental impairment (developmental delay, cerebral palsy, seizure disorder, profound hearing or vision loss) at 2 years of corrected age.

resultsFollow-up data were available for 601 of 653 (92%) eligible participants. Of the 296 infants assigned to the higher threshold group, 147 (50%) died or survived with neurodevelopmental impairment, as compared with 120 (39%) of 305 infants assigned to the lower threshold group (OR 1.54, 95% CI 1.09 to 2.17, p=0.017).

conclusionsInfants randomised to a higher platelet transfusion threshold of 50×10 TRIAL REGISTRATION NUMBER: ISRCTN87736839.

Indexed as

Infant, PrematureThrombocytopeniaChildChild, PreschoolGestational AgeHemorrhageHumansInfantInfant, NewbornPlatelet TransfusionChild DevelopmentIntensive Care Units, NeonatalNeonatology

Identifiers

PMID36810309
PMCPMC10447411
OpenAlexW4321613064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.